Fate Therapeutics
FATE
#9046
Rank
ยฃ93.55 M
Marketcap
ยฃ0.81
Share price
-1.82%
Change (1 day)
-61.98%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ1.35 M12.52%
2024ยฃ1.2 M-44.15%
2023ยฃ2.15 M-89.19%
2022ยฃ19.92 M-20.28%
2021ยฃ24.99 M31.2%
2020ยฃ19.05 M9.95%
2019ยฃ17.32 M59.52%
2018ยฃ10.86 M1415.4%
2017ยฃ0.71 M181.93%
2016ยฃ0.25 M-79.05%
2015ยฃ1.21 M-17.49%
2014ยฃ1.47 M-81.78%
2013ยฃ8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sarepta Therapeutics
SRPT
ยฃ2.3 Mยฃ22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
ยฃ3.56 Mยฃ85.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ3.49 Mยฃ32.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
ยฃ21.53 Mยฃ35.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.71 Mยฃ30.9 M๐Ÿ‡บ๐Ÿ‡ธ USA